Volume 39, Number 8, 1642-1648, DOI: 10.1007/BF02087770

Published in partnership with the

Logo

Gastroenterology Research Group

An evaluation of antimicrobial treatment for whipple's disease
Tetracycline versus trimethoprim-sulfamethoxazole

Gerhard E. Feurle and Thomas Marth

View Related Documents

Abstract

Whipple's disease is a multisystemic disorder in which almost all organ systems can be invaded by rod-shaped bacteria. Without extended antimicrobial therapy, its course is lethal. Empirically, treatment consists of tetracyclines given for one to two years. Trimethoprim-sulfamethoxazole, a compound that crosses the blood-brain barrier, has been suggested as an alternative when patients were observed with progressive cerebral involvement. There has never been a formal evaluation of the selection of antibiotics for the treatment of Whipple's disease. In the present nonrandomized, partially retrospective study, we compared the result of two treatment regimens in 30 patients, all examined personally. Twenty-two patients were treated with tetracycline and eight patients with trimethoprim-sulfamethoxazole. In five patients, therapy with tetracycline was changed to another antimicrobial agent because of treatment failure or drug intolerance. The main treatment measure was disappearance of the clinical symptoms such as weight loss, arthritis, malabsorption, fever, edema, central nervous system manifestations, lymphadenopathy, and congestive heart failure. Drug intolerance requiring a change of medication was also considered a treatment failure. We found that trimethoprim-sulfamethoxazole induced complete clinical remission in 12 of 13 treatment cycles, tetracycline in 13 of 22 treatment cycles (P<0.05; mean="" difference="" 33%;="" 95%="" confidence="" interval="" 8%="" to="" 58%).="" trimethoprim-sulfamethoxazole="" was="" also="" more="" efficacious="" than="" tetracycline="" in="" the="" treatment="" of="" cerebral="" whipple's="" disease.="" however,="" trimethoprim-sulfamethoxazole="" did="" not="" prevent="" cerebral="" manifestations="" in="" all="" cases.="" the="" only="" deaths="" due="" to="" whipple's="" disease="" occurred="" in="" patients="" with="" cerebral="" involvement.="" it="" is="" concluded="" that="" treatment="" with="" trimethoprim-sulfamethoxazole="" was="" significantly="" superior="" to="" that="" with="" tetracycline="" in="" inducing="" clinical="" remission="" of="" whipple's="" disease.="" a="" more="" active="" antimicrobial="" regimen="" is="" necessary="" to="" treat="" cerebral="">

Key words  Whipple's disease - treatment - tetracycline - trimethoprim-sulfamethoxazole - co-trimoxazole - therapy

Fulltext Preview

Image of the first page of the fulltext document